Navigation Links
Ultracold matter technology from CU and SRI International licensed to Boulder's ColdQuanta
Date:3/19/2012

ColdQuanta Inc. of Boulder and the University of Colorado have finalized an agreement allowing ColdQuanta to commercialize cutting-edge physics research developed by CU-Boulder and SRI International. The licensed technology centers on Bose-Einstein Condensate, or BEC, a new form of matter created just above absolute zero.

Ultracold matter such as BEC can be used to dramatically increase the performance of devices such as gyroscopes, accelerometers, gravimeters and magnetometers because of its strong interaction with gravity and magnetic fields as compared with laser-based devices. BEC also has potential applications in a wide range of research and commercial settings, ranging from atomic clocks to improved navigation of submarines and spacecraft, and even quantum computing.

"We are delighted that this license agreement has been finalized," said ColdQuanta CEO Rainer Kunz. "It's a great example of the university's strong support for commercializing BEC and cold atom technology born out of CU and SRI International, and will ultimately boost advances in the ultracold applications field."

"Cold atom research has great potential for fields such as instrumentation and cryptography," added Chris Lantman, senior director of business development at SRI International of Menlo Park, Calif. "We are pleased that ColdQuanta will commercialize this important technology and look forward to new applications of our physics R&D."

Initially theorized by Satyendra Bose and Albert Einstein in the 1920s, BEC was achieved for the first time at JILA -- a joint institute of CU-Boulder and the National Institute of Standards and Technology -- by Eric Cornell and Carl Wieman, who received a Nobel Prize in 2001 for their work. ColdQuanta was founded in 2007 to commercialize work by CU-Boulder physics professor and JILA Fellow Dana Anderson to develop streamlined devices for BEC experiments.

"Startup companies like ColdQuanta play a pivotal part in the transition of an entirely new scientific domain into the realm of practical applications," said Anderson. "By now we have come full circle, so that they contribute to our scientific progress here at CU as much as our academic research advances their R&D progress."

"We're glad to see this forward-looking technology achieve commercial penetration, in addition to the strong academic interest," added Ted Weverka, a licensing manager at CU. "ColdQuanta is just the adventurous company to make this happen."

After optioning the technology in 2007, ColdQuanta received a $100,000 Proof of Concept investment from the CU Technology Transfer Office to help bring it to market. Since then, the company has been awarded contracts from the Army, Navy, NASA and the National Science Foundation, which have helped expand its array of products and core competencies beyond ultra-high vacuum, or UHV, design and opto-mechanical and atom chip design, to include UHV processing, systems controls, and diverse glass and silicon bonding expertise. The company sells to research labs and industry nationally and overseas. The company also has partnered with CU-Boulder and SRI International to provide critical UHV components for a major quantum computing project led by the University of Wisconsin.


'/>"/>

Contact: Lindsay Lennox
lindsay.lennox@cu.edu
303-735-5518
University of Colorado at Boulder
Source:Eurekalert  

Related biology news :

1. People matter in climate change models
2. Shedding light on the dark matter of the genome
3. Location matters: For invasive aquatic species, its better to start upstream
4. The body rids itself of damage when it really matters
5. Size matters: Length of songbirds’ playlists linked to brain region proportions
6. Researchers sequence dark matter of life
7. NSF establishes Triangle (NC) Center for Soft Matter Research
8. Study finds crop performance matters when evaluating greenhouse gas emissions
9. In cell culture, like real estate, the neighborhood matters
10. Johns Hopkins scientists expose cancer cells universal dark matter
11. Rice-born detector finds heaviest antimatter
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ultracold matter technology from CU and SRI International licensed to Boulder's ColdQuanta
(Date:12/6/2016)... Valencell , the leading innovator in ... a third consecutive year of triple digit growth for ... with a 360 percent increase in companies who have ... driven by sales of its wrist and ear Benchmark™ ... technology for hearables for fitness and healthcare applications. ...
(Date:11/30/2016)... and WARSAW, Poland , Nov. 30, 2016 Not many ... of the most crucial aspects of recovery so we need to do it well. ... risks, including heart problems, high blood pressure, stroke, diabetes, and even cancer. ... and find a Christmas present that could help them to manage their sleep quality? ... ...
(Date:11/28/2016)... "The biometric system market ... The biometric system market is in the growth stage ... future. The biometric system market is expected to be ... CAGR of 16.79% between 2016 and 2022. Government initiative ... in smartphones, rising use of biometric technology in financial ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... 8, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... developing and commercializing products to treat rare diseases where ... it will be hosting an Investor Webcast Event Friday, ... origins of innate defense regulators (IDRs) as a new ... mucositis and the recently announced and published Phase 2 ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... ), a leading commercial provider of clinically actionable ... cancer patients, announces that clinical data featuring its ... concordance to tissue biopsy for the detection of ... The results from research sponsored by Sara Cannon ...
(Date:12/7/2016)... 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical ... immunotherapeutic products for the treatment of cancer, today ... Manufacturing Development Program with Cytovance Biologics ( ... oregovomab antibody product. Supported by recent positive interim ... in ovarian cancer patients, OncoQuest has engaged Cytovance ...
(Date:12/7/2016)... 7, 2016  Vyriad Inc. announced today the appointment ... Board of Directors. "We are delighted to ... business and develop our oncolytic viruses as the next ... Stephen Russell , MD, PhD, CEO of Vyriad. "Al ... vision and passion for making a difference for cancer ...
Breaking Biology Technology: